Agenus closed its previously disclosed $141 million strategic collaboration with Zydus Lifesciences, which is designed to accelerate global development and…
Funding accelerates clinical rollout of glycan biomarkers for aging and inflammation, pushing them into mainstream preventive care. GlycanAge, a London-based…
